Literature DB >> 24092047

Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.

Iain J Nixon1, Frank L Palmer, Paul Lakin, Michael M Kattan, Nancy Y Lee, Ian Ganly.   

Abstract

IMPORTANCE: Traditional prognostic models for squamous cell carcinoma of the head and neck are based on the TNM staging system. However, there is growing evidence that tumor volume (TV) may be a more accurate predictor of outcome.
OBJECTIVE: To determine whether pathologic TV (pTV) in patients with oropharyngeal squamous cell carcinoma treated surgically is a more significant predictor of outcome compared with pathologic tumor (pT) stage. DESIGN, SETTING, AND PARTICIPANTS: Review of patients whose treatment was managed between January 1, 1985, and December 2005 at a US tertiary referral cancer center. The participants included 159 patients who had undergone primary surgery for oropharyngeal squamous cell carcinoma and had 3 dimensions reported on histopathologic testing. MAIN OUTCOMES AND MEASURES: The pTV was calculated as the product of the 3 dimensions expressed in cubic centimeters. For comparison of pT stage with pTV in outcome prediction, concordance indexes were generated using the bootstrap method (n = 1000) to quantify the predictive accuracy of recurrence and survival outcomes. Concordance indexes were then compared and a significant difference was considered when P < .05.
RESULTS: The median age of the patients was 59 years (range, 22-84 years) and 106 were male (67%). Sites of the tumors were base of the tongue (86 patients [54%]), tonsil (48 [30%]), soft palate (24 [15%]), and posterior pharyngeal wall (1 [1%]). The median follow-up time was 64 months (range, 1-272 months). The median tumor volume was 6.8 cm3 (range, 0.1-162.5 cm³). Pathologic TV was a significant predictor of disease-specific mortality. Unlike pT stage, pTV was a significant predictor of local recurrence, regional recurrence, and distant recurrence. Comparison of concordance indexes showed that pTV was a significantly better predictor of disease-specific mortality, local recurrence, and distant recurrence (all P < .05). CONCLUSIONS AND RELEVANCE: Pathologic TV outperforms pT stage in the prediction of outcome following surgical treatment of oropharyngeal cancer. Tumor volume should be considered in the design of prospective surgical trials.

Entities:  

Mesh:

Year:  2013        PMID: 24092047     DOI: 10.1001/jamaoto.2013.4973

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  6 in total

1.  Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients.

Authors:  Sree Harsha Tirumani; Atul B Shinagare; Ailbhe C O'Neill; Mizuki Nishino; Michael H Rosenthal; Nikhil H Ramaiya
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

2.  Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.

Authors:  Kara S Davis; Chwee Ming Lim; David A Clump; Dwight E Heron; James P Ohr; Seungwon Kim; Umamaheswar Duvvuri; Jonas T Johnson; Robert L Ferris
Journal:  Head Neck       Date:  2015-12-17       Impact factor: 3.147

3.  CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.

Authors:  Subha Perni; Abdallah S R Mohamed; Jacob Scott; Heiko Enderling; Adam S Garden; G Brandon Gunn; David I Rosenthal; Clifton D Fuller
Journal:  Oral Oncol       Date:  2016-11-04       Impact factor: 5.337

4.  Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.

Authors:  Austin K Mattox; Gypsyamber D'Souza; Zubair Khan; Hailey Allen; Stephanie Henson; Tanguy Y Seiwert; Wayne Koch; Drew M Pardoll; Carole Fakhry
Journal:  Oral Oncol       Date:  2022-03-22       Impact factor: 5.972

5.  Palate Squamous Cell Carcinomas:A Ten-Year Single Institute Experience.

Authors:  Adrian PĂtru; Valeriu Şurlin; Claudiu MĂrgĂritescu; Eduard CiucĂ; Otilia Clara MĂrgĂritescu; Adrian Camen
Journal:  Curr Health Sci J       Date:  2020-12-31

6.  Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.

Authors:  Eduardo-Pereira Guimarães; Marina-Lara de Carli; Felipe-Fornias Sperandio; João-Adolfo-Costa Hanemann; Alessandro-Antônio-Costa Pereira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.